Literature DB >> 1782980

Pharmacokinetics of intravenous and oral chlordesmethyldiazepam in patients on regular haemodialysis.

J Sennesael1, D Verbeelen, L Vanhaelst, R Pirola, S R Bareggi.   

Abstract

The pharmacokinetics of a single 2 mg IV dose of chlordesmethyldiazepam has been studied in 11 patients with renal failure on regular haemodialysis and in 11 age-matched healthy controls. The kinetics was also examined after a single 2 mg oral dose in 6 of the 11 renal failure patients. After intravenous administration the kinetics of total chlordesmethyldiazepam in renal patients and controls were the same. The unbound fraction of the drug in renal patients was higher (5.5%) than in controls (2.9%). Correction for differences in protein binding revealed a reduced apparent volume of distribution (47 vs. 140 l.kg-1) and a reduced clearance (5.0 vs. 10.5 ml.min-1.kg-1) in the patients. The systemic availability of oral chlordesmethyldiazepam was good (82%) despite a relatively slow absorption rate.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1782980     DOI: 10.1007/BF00280109

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  27 in total

1.  Impaired absorption of desmethyldiazepam from clorazepate by magnesium aluminum hydroxide.

Authors:  R I Shader; A Georgotas; D J Greenblatt; J S Harmatz; M D Allen
Journal:  Clin Pharmacol Ther       Date:  1978-09       Impact factor: 6.875

2.  Effects of end-stage renal disease and aluminum hydroxide on temazepam kinetics.

Authors:  P D Kroboth; R B Smith; R Rault; M R Silver; M I Sorkin; J B Puschett; R P Juhl
Journal:  Clin Pharmacol Ther       Date:  1985-04       Impact factor: 6.875

3.  Analysis of chlorodesmethyldiazepam and its metabolites in plasma and urine.

Authors:  L Zecca; P Ferrario; R Pirola; S R Bareggi
Journal:  J Chromatogr       Date:  1987-09-25

4.  Influence of magnesium and aluminum hydroxide mixture on chlordiazepoxide absorption.

Authors:  D J Greenblatt; R I Shader; J S Harmatz; K Franke; J Koch-Weser
Journal:  Clin Pharmacol Ther       Date:  1976-02       Impact factor: 6.875

5.  Pharmacokinetics of chlordesmethyldiazepam after single-dose oral administration in humans.

Authors:  S R Bareggi; R Pirola; S Leva; L Zecca
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1986 Jul-Sep       Impact factor: 2.441

6.  Clobazam kinetics: intrasubject variability and effect of food on adsorption.

Authors:  M Divoll; D J Greenblatt; D A Ciraulo; S K Puri; I Ho; R I Shader
Journal:  J Clin Pharmacol       Date:  1982-01       Impact factor: 3.126

7.  Diazepam kinetics in patients with renal insufficiency or hyperthyroidism.

Authors:  H R Ochs; D J Greenblatt; H J Kaschell; U Klehr; M Divoll; D R Abernethy
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

8.  Pharmacokinetics and bioavailability of intravenous and oral chlordesmethyldiazepam in humans.

Authors:  S R Bareggi; G Truci; S Leva; L Zecca; R Pirola; S Smirne
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

9.  Absorption rate, blood concentrations, and early response to oral chlordiazepoxide.

Authors:  D J Greenblatt; R I Shader; J S Harmatz; K Franke; J Koch-Weser
Journal:  Am J Psychiatry       Date:  1977-05       Impact factor: 18.112

10.  Renal disease, age, and oxazepam kinetics.

Authors:  T G Murray; S T Chiang; H H Koepke; B R Walker
Journal:  Clin Pharmacol Ther       Date:  1981-12       Impact factor: 6.875

View more
  1 in total

1.  Effects of liver disease on the pharmacokinetics of intravenous and oral chlordesmethyldiazepam.

Authors:  S R Bareggi; R Pirola; P Potvin; G Devis
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.